Waqar M. Haque, MD

Assistant Professor of Clinical Radiation Oncology, Institute for Academic Medicine
Assistant Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Haque is a native Houstonian and attended medical school at Baylor College of Medicine. He graduated in 2010 as a member of the Alpha Omega Alpha Medical Honor Society.  He completed residency in radiation oncology at the University of Texas Medical Branch in Galveston, during which he also spent time training at the MD Anderson Cancer Center.

Publications

Utilization of intensity modulated radiation therapy for anal cancer in the United States
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Journal of Gastrointestinal Oncology, vol 9, no. 3, pp. 466-477. DOI: 10.21037/jgo.2018.03.03

Utilization of hysterectomy following chemoradiation for IB2/IIA2 cervical cancer in the national cancer data base
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Anticancer Research, vol 38, no. 5, pp. 3175-3179. DOI: 10.21873/anticanres.12581

Sequential versus concurrent chemoradiation therapy by surgical margin status in resected non-small cell lung cancer
Verma, V, Moreno, AC, Haque, W, Fang, P & Lin, SH 2018, JNCCN Journal of the National Comprehensive Cancer Network, vol 16, no. 5, pp. 508-516. DOI: 10.6004/jnccn.2018.7007

Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
Haque, W, Verma, V, Hatch, S, Suzanne Klimberg, V, Brian Butler, E & Teh, BS 2018, Breast Cancer Research and Treatment, pp. 1-9. DOI: 10.1007/s10549-018-4801-3

Omission of radiotherapy in elderly women with early stage metaplastic breast cancer
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Breast, vol 38, pp. 154-159. DOI: 10.1016/j.breast.2018.01.005

Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA
Haque, W, Verma, V, Lewis, GD, Lo, SS, Butler, EB & Teh, BS 2018, Future Oncology, vol 14, no. 9, pp. 819-827. DOI: 10.2217/fon-2017-0536

Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Journal of Gastrointestinal Oncology, vol 9, no. 2, pp. 282-294. DOI: 10.21037/jgo.2017.11.14

The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: A National Cancer Data Base analysis
Huang, Y, Chen, W, Haque, W, Verma, V, Xing, Y, Teh, BS & Brian Butler, E 2018, Cancer Medicine. DOI: 10.1002/cam4.1377

Clinical benefit to regionalization of care for muscle invasive bladder cancer
Haque, W, Butler, EB & Teh, BS 2018, Translational Andrology and Urology, vol 7, pp. S98-S100. DOI: 10.21037/tau.2018.01.05

Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base
Moreno, AC, Haque, W, Verma, V, Fang, P & Lin, SH 2018, Annals of Surgical Oncology, pp. 1-9. DOI: 10.1245/s10434-018-6399-4

Radiation dose in neoadjuvant chemoradiation therapy for esophageal cancer: Patterns of care and outcomes from the National Cancer Data Base
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Journal of Gastrointestinal Oncology, vol 9, no. 1, pp. 80-89. DOI: 10.21037/jgo.2017.09.12

Trends in Cardiac Mortality in Patients With Locally Advanced Non-Small Cell Lung Cancer
Haque, W, Verma, V, Fakhreddine, M, Butler, EB, Teh, BS & Simone, CB 2018, International Journal of Radiation Oncology Biology Physics, vol 100, no. 2, pp. 470-477. DOI: 10.1016/j.ijrobp.2017.10.031

Metaplastic Breast Cancer: Practice Patterns, Outcomes, and the Role of Radiotherapy
Haque, W, Verma, V, Naik, N, Butler, EB & Teh, BS 2018, Annals of Surgical Oncology, pp. 1-9. DOI: 10.1245/s10434-017-6316-2

Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, American Journal of Clinical Oncology: Cancer Clinical Trials, vol 41, no. 2, pp. 167-172. DOI: 10.1097/COC.0000000000000417

Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Clinical Genitourinary Cancer. DOI: 10.1016/j.clgc.2018.03.015

Adjuvant Management of Pathologic Node–Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer
Polamraju, P, Haque, W, Verma, V, Wiederhold, L, Hatch, S, Butler, EB & Teh, BS 2018, Clinical Colorectal Cancer. DOI: 10.1016/j.clcc.2018.04.001

The long-term sequelae of palliative radiation therapy to lumbosacral spine using conventional PA-single portal technique
Hsiao, KY, Wang, HC, Fung, SH, Haque, W, Butler, EB & Teh, BS 2018, Practical Radiation Oncology. DOI: 10.1016/j.prro.2018.04.003

Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base
Haque, W, Verma, V, Bernicker, E, Butler, EB & Teh, BS 2017, Acta Oncologica, pp. 1-8. DOI: 10.1080/0284186X.2017.1409435

The role of adjuvant chemotherapy in locally advanced bladder cancer
Haque, W, Lewis, GD, Verma, V, Darcourt, JG, Butler, EB & Teh, BS 2017, Acta Oncologica, pp. 1-7. DOI: 10.1080/0284186X.2017.1415461

Addition of chemotherapy to hypofractionated radiotherapy for glioblastoma: practice patterns, outcomes, and predictors of survival
Haque, W, Verma, V, Butler, EB & Teh, BS 2017, Journal of Neuro-Oncology, pp. 1-9. DOI: 10.1007/s11060-017-2654-y